Net sales grew 2.7% year-over-year, with profit attributable to owners of parent up 7.7%, despite a 16.2% drop in operating profit. Segment results were mixed, with Fine Chemicals and Life Science showing growth, while Industrial Products declined. Full-year guidance remains unchanged.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.